News | June 25, 2025
Bachem expands multi-site production capacities to meet rising demand
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plants by volume
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
Sun Pharma gets 8 observations from USFDA for Halol facility
Oxcarbazepine ER Tablets (RLD Oxtellar XR) had estimated annual sales of US$ 206 million in the US (IQVIA MAT April 2025)
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
_256_384.jpg)
33rd lab in Thyrocare’s expanding network to bring advanced, affordable diagnostic services across the Kashmir Valley
Subscribe To Our Newsletter & Stay Updated
